Image Analysis Group (IAG) will attend Biotech Week Boston 2026 from 22 to 25 September. Biotech Week is an outsourcing conversation as much as a scientific one, which makes it a practical place to discuss how imaging gets delivered rather than only what it measures.
Event details:
- Dates: 22–25 September 2026
Time: 08:30–18:00 EDT (13:30–23:00 BST)
Location: Boston Convention & Exhibition Center, Boston, Massachusetts, USA
Who should meet IAG at Biotech Week Boston
- Clinical operations and outsourcing leads deciding how and when to bring in an imaging CRO
Program leaders at smaller sponsors with no dedicated imaging function
Teams preparing an imaging RFP and unsure what to specify
CRO and CDMO partners looking for a specialist imaging provider for complex studies
Who is attending from Image Analysis Group (IAG)
Mike Fisher, VP, Business Development & Strategic Partnerships, will represent IAG at Biotech Week Boston 2026.
If you are weighing up how and when to outsource imaging, get in touch to arrange a time during the week. It is a useful conversation to have before the RFP goes out rather than after.
To follow IAG’s work between events, including upcoming webinars on centralized imaging, AI-enabled endpoints and radiomics, follow us on LinkedIn
About Image Analysis Group (IAG)
Image Analysis Group (IAG) is a trusted partner to life sciences companies, combining deep expertise in medical imaging with the innovative power of its proprietary platform, DYNAMIKA™, to de-risk clinical development and accelerate the delivery of lifesaving therapies to patients. The IAG team designs and executes the imaging part of clinical trials that rely on radiological endpoints to demonstrate the safety and efficacy of new drug candidates. By using AI-powered endpoints and automating data management processes, with IAG you accelerate start-up and database lock, gain real-time visibility on trial progress, ensure clean data for regulatory submissions, and maximize patient recruitment speed.
For nearly 20 years, IAG has supported more than 700 clinical trials globally, helping biotech and pharmaceutical sponsors make confident, data-driven decisions on their development portfolios.